Real-World Evidence
IQVIA offers several real-world evidence solutions
The use of patient-level data can add depth and granularity to analyses that support the demonstration of a product value.
- To identify unmeet clinical need in routine care and design IQVIA CORE Diabetes Model simulations that reflect routine clinical practice in a given country;
- To evaluate effectiveness of drugs and use this information as input for cost-effectiveness analyses;
- To determine the effectiveness of a drug in patient populations not evaluated in clinical trials;
- To use demographic, clinical and medication data for diabetic sub populations to identify target patient groups for early stage cost effectiveness analysis;
- To monitor the uptake and safety of a drug in real-life settings to support discussions with payers and regulatory authorities.
Covering more than 300 million patient lives, LifeLink data assets can provide diabetes insights in several markets. Assets include:
- Health plan claims data
- Longitudinal prescription data
- Electronic medical record
- Hospital Treatment Insight
- Longitudinal patient databases
Of particular interest to researchers in diabetes is our French diabetes cohort, which was specifically designed to answer questions from the diabetes community in type 1 and type
2 diabetes.
Click
here
to learn more about IQVIA patient-level data assets.
|
